Georgia Retina

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME	diabetic macular edema	Active, not recruiting	Phase 3	2026-10-08	NCT04108156
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME	diabetic macular edema	Active, not recruiting	Phase 3	2026-10-02	NCT07449936
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)	Geographic Atrophy, eye disorder, macular degeneration, retinal degeneration, retinal disorder	Recruiting	Phase 2 / Phase 3	2026-09-30	NCT06635148
A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)	diabetic macular edema	Active, not recruiting	Phase 3	2026-09-18	NCT06491914

Clinical trials